OPT 2.79% 87.0¢ opthea limited

These are the primary and secondary endpoints: Primary Outcome...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,850 Posts.
    lightbulb Created with Sketch. 655

    These are the primary and secondary endpoints:

    Primary Outcome Measures :
    1. Mean change in Early Treatment Diabetic Retinopathy Study (ETDRS) best corrected visual acuity (BCVA) [ Time Frame: Baseline to Week 24 ]
    Secondary Outcome Measures :
    1. Proportion of participants gaining 15 or more ETDRS BCVA letters [ Time Frame: Baseline to Week 24 ]
    2. Area under the ETDRS BCVA over time curve [ Time Frame: Baseline to Week 24 ]
    3. Change in central subfield thickness (CST) on spectral domain optical coherence tomography (SD-OCT) [ Time Frame: Baseline to Week 24 ]
    4. Change in intra-retinal fluid and sub-retinal fluid on SD-OCT [ Time Frame: Baseline to Week 24 ]
    5. Proportion of participants losing 15 or more letters (on ETDRS BCVA chart) [ Time Frame: Baseline to Week 24
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
87.0¢
Change
-0.025(2.79%)
Mkt cap ! $1.064B
Open High Low Value Volume
88.5¢ 88.5¢ 85.8¢ $1.327M 1.530M

Buyers (Bids)

No. Vol. Price($)
17 22858 86.5¢
 

Sellers (Offers)

Price($) Vol. No.
87.0¢ 24250 14
View Market Depth
Last trade - 11.09am 08/10/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.